Cargando…

CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab

Detalles Bibliográficos
Autores principales: Chen, Shih-Hsin, Edeline, Julien, Shiu, Kai-Keen, Benafif, Sarah, Wong, Sofia, Groves, Ashley, Bridgewater, John, Ganeshan, Balaji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601537/
http://dx.doi.org/10.1186/1470-7330-15-S1-S12
_version_ 1782394564598824960
author Chen, Shih-Hsin
Edeline, Julien
Shiu, Kai-Keen
Benafif, Sarah
Wong, Sofia
Groves, Ashley
Bridgewater, John
Ganeshan, Balaji
author_facet Chen, Shih-Hsin
Edeline, Julien
Shiu, Kai-Keen
Benafif, Sarah
Wong, Sofia
Groves, Ashley
Bridgewater, John
Ganeshan, Balaji
author_sort Chen, Shih-Hsin
collection PubMed
description
format Online
Article
Text
id pubmed-4601537
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46015372015-10-13 CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab Chen, Shih-Hsin Edeline, Julien Shiu, Kai-Keen Benafif, Sarah Wong, Sofia Groves, Ashley Bridgewater, John Ganeshan, Balaji Cancer Imaging Speaker Presentation BioMed Central 2015-10-02 /pmc/articles/PMC4601537/ http://dx.doi.org/10.1186/1470-7330-15-S1-S12 Text en Copyright © 2015 Chen et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Speaker Presentation
Chen, Shih-Hsin
Edeline, Julien
Shiu, Kai-Keen
Benafif, Sarah
Wong, Sofia
Groves, Ashley
Bridgewater, John
Ganeshan, Balaji
CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title_full CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title_fullStr CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title_full_unstemmed CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title_short CT texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
title_sort ct texture analysis as a prognostic marker in metastatic colorectal cancer patients treated with bevacizumab
topic Speaker Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601537/
http://dx.doi.org/10.1186/1470-7330-15-S1-S12
work_keys_str_mv AT chenshihhsin cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT edelinejulien cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT shiukaikeen cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT benafifsarah cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT wongsofia cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT grovesashley cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT bridgewaterjohn cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab
AT ganeshanbalaji cttextureanalysisasaprognosticmarkerinmetastaticcolorectalcancerpatientstreatedwithbevacizumab